Edesa Biotech EDSA
NASDAQ EDSA
$3.86 -0.15 (-3.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Gains from Sales and Divestitures (2019 - 2020)

Updated

Edesa Biotech (EDSA) reported Gains from Sales and Divestitures of -$3,670 for FY2014 (year ended Aug 31, 2014).

Analysis

Edesa Biotech (EDSA) Gains from Sales and Divestitures (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Edesa Biotech 37.18 Mn 37.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 -436.00
Jun 30, 2019 2,172.00
API Access

Edesa Biotech Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=EDSA&period=max&api_key=YOUR_API_KEY